Health Policy Watch: Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market
“A ‘public interest R&D’ model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday…” (Ren, 10/30).